Bogle Grant C. — SEC insider filings

SEC reporting owner CIK 1646675. 12 insider filings on record with FilingPulse; latest filed 2026-11-09.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-06-15 to 2026-11-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Epizyme, Inc. (EPZM)President and CEO, Director6——15
Nuvalent, Inc. (NUVL)Director4——9
Immuneering Corp (IMRX)Director2——1

Insider filings — Bogle Grant C.

FiledFormIssuerReported transactionsSource
2026-11-093Immuneering Corp (IMRX)Holdings only — no transactions reportedEDGAR
2026-11-094Immuneering Corp (IMRX)Grant/award (A): 66,700 (derivative) @ $0EDGAR
2026-07-154Nuvalent, Inc. (NUVL)Code (U): 3,714 @ $124 · Disposition to issuer (D): 5,577 · Disposition to issuer (D): 4,851 (derivative) · Disposition to issuer (D): 4,147 (derivative)EDGAR
2026-06-184Nuvalent, Inc. (NUVL)Grant/award (A): 3,444 @ $0EDGAR
2025-06-204Nuvalent, Inc. (NUVL)Grant/award (A): 2,647 @ $0 · Grant/award (A): 4,147 (derivative) @ $0EDGAR
2024-12-094Nuvalent, Inc. (NUVL)Grant/award (A): 3,200 @ $0 · Grant/award (A): 4,851 (derivative) @ $0EDGAR
2022-08-164Epizyme, Inc. (EPZM)Disposition to issuer (D): 84,170 · Disposition to issuer (D): 175,000EDGAR
2022-08-114Epizyme, Inc. (EPZM)Option exercise (M): 800,000 @ $1.39 · Tax withholding (F): 746,307 @ $1.39 · Option exercise (M): 417,500 @ $1.41 · Tax withholding (F): 395,083 @ $1.41 · Option exercise (M): 800,000 (derivative) @ $0 · Option exercise (M): 417,500 (derivative) @ $0EDGAR
2022-03-214Epizyme, Inc. (EPZM)Grant/award (A): 800,000 (derivative) @ $0EDGAR
2022-02-044Epizyme, Inc. (EPZM)Grant/award (A): 87,500 @ $0 · Grant/award (A): 417,500 (derivative) @ $0EDGAR
2021-08-184Epizyme, Inc. (EPZM)Grant/award (A): 87,500 @ $0 · Grant/award (A): 417,500 (derivative) @ $0EDGAR
2021-06-154Epizyme, Inc. (EPZM)Grant/award (A): 8,060 @ $0 · Grant/award (A): 40,559 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1646675 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs